We have moved the investment part of our business to our associated venture capital firm, i&i Biotech Fund I. We target early-stage Life Science startups that often build on decades of research and have the potential for breakthrough discoveries. We are trying to help them in their transition from purely scientific projects to functional companies. We focus mainly on projects from European Union member states, our core expertise lies in Central and Eastern Europe.